BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18194094)

  • 1. Complete elimination is a difficult goal for trachoma programs in severely affected communities.
    Gill DA; Lakew T; Alemayehu W; Melese M; Zhou Z; House JI; Hong KC; Ray KJ; Gandhi N; Whitcher JP; Gaynor BD; Lietman TM
    Clin Infect Dis; 2008 Feb; 46(4):564-6. PubMed ID: 18194094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
    Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
    JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?
    Bird M; Dawson CR; Schachter JS; Miao Y; Shama A; Osman A; Bassem A; Lietman TM
    J Infect Dis; 2003 May; 187(10):1669-73. PubMed ID: 12721948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
    BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic therapy for trachoma.
    Prescrire Int; 2009 Aug; 18(102):176-7. PubMed ID: 19750586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
    Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
    Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass antibiotic treatment and community protection in trachoma control programs.
    Chidambaram JD; Melese M; Alemayehu W; Yi E; Prabriputaloong T; Lee DC; Cevallos V; Zhou Z; Whitcher JP; Gaynor BD; Lietman TM
    Clin Infect Dis; 2004 Nov; 39(9):e95-7. PubMed ID: 15494901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia on children and flies after mass antibiotic treatment for trachoma.
    Lee S; Alemayehu W; Melese M; Lakew T; Lee D; Yi E; Cevallos V; Donnellan C; Zhou Z; Chidambaram JD; Gaynor BD; Whitcher JP; Lietman TM
    Am J Trop Med Hyg; 2007 Jan; 76(1):129-31. PubMed ID: 17255240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.
    Tilahun Z; Fenta TG
    BMC Ophthalmol; 2018 Aug; 18(1):193. PubMed ID: 30081851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.
    Keenan JD; Lakew T; Alemayehu W; Melese M; Porco TC; Yi E; House JI; Zhou Z; Ray KJ; Acharya NR; Whitcher JP; Gaynor BD; Lietman TM
    Am J Trop Med Hyg; 2010 Mar; 82(3):482-7. PubMed ID: 20207878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
    Lakew T; House J; Hong KC; Yi E; Alemayehu W; Melese M; Zhou Z; Ray K; Chin S; Romero E; Keenan J; Whitcher JP; Gaynor BD; Lietman TM
    PLoS Negl Trop Dis; 2009; 3(2):e376. PubMed ID: 19190781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
    Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
    Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin in control of trachoma.
    Schachter J; West SK; Mabey D; Dawson CR; Bobo L; Bailey R; Vitale S; Quinn TC; Sheta A; Sallam S; Mkocha H; Mabey D; Faal H
    Lancet; 1999 Aug; 354(9179):630-5. PubMed ID: 10466664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing.
    Lietman TM; Gebre T; Abdou A; Alemayehu W; Emerson P; Blumberg S; Keenan JD; Porco TC
    Epidemics; 2015 Jun; 11():85-91. PubMed ID: 25979286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.